Physician profile
Albert Tawil
NPI 1497863294
$2,872.83
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,118 · 2020: $754.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $975.96 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $224.71 | 2019-2020 | |
| Glaxosmithkline, LLC. | $209.56 | 2019-2020 | |
| Amgen INC. | $193.25 | 2019-2020 | |
| Astellas Pharma US INC | $159.13 | 2019-2020 | |
| Genentech USA, INC. | $158.32 | 2019 | |
| Allergan, INC. | $156.76 | 2019-2020 | |
| Abbvie INC. | $145.81 | 2019-2020 | |
| Mylan Specialty L.P. | $137.84 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.36 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $89.85 | 2019 | |
| Janssen Pharmaceuticals, INC | $78.26 | 2019 | |
| Pfizer INC. | $55.84 | 2019 | |
| Arbor Pharmaceuticals, INC. | $46.62 | 2019 | |
| Sanofi-Aventis U.S. LLC | $29.10 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $23.76 | 2019 | |
| Jazz Pharmaceuticals INC. | $23.43 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.72 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.57 | 2019 | |
| Smith+Nephew, INC. | $13.18 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Tawil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.